Dexmedetomidine in Septic Shock: DecatSepsis Trial
In this episode of the Saving Lives Podcast, we dive into the DecatSepsis trial, exploring the role of dexmedetomidine in reducing mortality and managing septic shock. Discover how this sedative could help mitigate the harmful effects of the hyperadrenergic state in septic patients. The Vasopressor & Inotrope Handbook I have written "The Vasopressor & Inotrope Handbook: A Practical Guide for Healthcare Professionals," a must-read for anyone caring for critically ill patients (check out the reviews)! You have several options to get a physical copy. Amazon: https://amzn.to/47qJZe1 (Affiliate Link) Signed & Personalized Copy: https://eddyjoemd.myshopify.com/products/the-vasopressor-inotrope-handbook My website: www.eddyjoemd.com Instagram: www.instagram.com/eddyjoemd X: www.x.com/eddyjoemd Facebook: www.facebook.com/eddyjoemd My Amazon store for resources you may find helpful: www.amazon.com/shop/eddyjoemd @eddyjoemd is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com Although great care has been taken to ensure that the information in this podcast is accurate, eddyjoemd, LLC shall not be held responsible or liable for its continued accuracy or any errors, omissions, inaccuracies, or consequences arising from it. Citation Ezz Al-Regal AR, Ramzy EA, Allah Atia AA, Emara MM. Dexmedetomidine for Reducing Mortality in Patients With Septic Shock A Randomized Controlled Trial (DecatSepsis). Chest. 2024 Jul 14:S0012-3692(24)04601-4. doi: 10.1016/j.chest.2024.06.3794. Epub ahead of print. PMID: 39004217.